CG Oncology (CGON) Gets Initiated With a Buy at Guggenheim
CG Oncology, Inc. (NASDAQ:CGON) is one of the best healthcare stocks with the highest upside. On October 7, CG Oncology, Inc.
Cg Oncology Inc. (CGON)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Decheng Capital Min Cui | 6,371,669 | $256,650,827 | 44.78% | |
| 2. | Braidwell LP Alex Karnal | 3,283,317 | $132,252,009 | 3.92% | |
| 3. | Kynam Capital Derrick Tang | 2,005,205 | $80,769,657 | -19% | 6.01% |
| 4. | OrbiMed Advisors Samuel Isaly | 1,726,850 | $69,557,518 | -9% | 1.63% |
| 5. | Avidity Partners Management David Witzke And Michael Gregory | 1,600,899 | $64,484,212 | +7% | 14.68% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.00 | 1,515,151 | $49,999,983.00 | 1,515,151 | 2025-09-11 | Filing | |
| $19.00 | 400,000 | $7,600,000.00 | 4,958,810 | 2024-01-29 | Filing | |
| $19.00 | 1,315 | $24,985.00 | 1,315 | 2024-01-29 | Filing | |
| $19.00 | 2,000 | $38,000.00 | 2,000 | 2024-01-29 | Filing | |
| $19.00 | 263,157 | $4,999,983.00 | 613,928 | 2024-01-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $41.43 | 1,000 | $41,430.00 | 0 | 2025-11-17 | Filing | |
| $43.25 | 1,000 | $43,250.00 | 0 | 2025-10-13 | Filing | |
| $43.99 | 5,903 | $259,672.97 | 0 | 2025-10-09 | Filing | |
| $40.09 | 5,000 | $200,450.00 | 0 | 2025-09-30 | Filing | |
| $39.19 | 12,755 | $499,868.45 | 0 | 2025-09-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,577,281 | $264,932,879 | 0% | |
| 2. | 5,512,779 | $222,054,736 | 0.04% | |
| 3. | 4,586,514 | $184,744,784 | 0% | |
| 4. | 3,865,802 | $155,714,505 | 0.01% | |
| 5. | 3,670,206 | $147,835,898 | 7.27% |
News See All
9 Best Healthcare Stocks with the Highest Upside
Talking about how people are feeling the impact of the shutdown, Dr.
Guggenheim Initiates CG Oncology (CGON) Coverage with $90 PT, Highlights Bladder Cancer Therapeutic Cretostimogene
CG Oncology Inc. (NASDAQ:CGON) is one of the best hot stocks to invest in. On October 8, Guggenheim analyst Brad Canino initiated coverage of CG Oncology with a Buy rating and $90 price target.
12 Best Hot Stocks to Invest In
On September 24, Ryan Detrick, Carson Group chief market strategist, joined CNBC's 'Power Lunch' to discuss why he still expects a strong end-of-year rally.
CG Oncology (CGON) PT Raised to $79 by Morgan Stanley on Strong Clinical Pipeline for Bladder Cancer Treatment
CG Oncology Inc. (NASDAQ:CGON) is one of the best new stocks to buy right now.
14 Best New Stocks to Buy Right Now
On September 15, Tom Sosnoff, Tastylive founder, joined 'Squawk Box' on CNBC to discuss the state of the IPO market and what to make of the surge of IPO offerings.
CG Oncology's Bladder Cancer Drug Shows Strong Clinical Data, Drives Optimism Despite Price Target Cut
CG Oncology Inc. (NASDAQ:CGON) is one of the best IPO stocks to buy according to Wall Street analysts.
H.C. Wainwright Reiterates a Buy on CG Oncology (CGON), Keeps the PT
CG Oncology, Inc. (NASDAQ:CGON) is one of the Best Small-Cap Growth Stocks to Buy Right Now. On August 11, Andres Y. Maldonado from H.C. Wainwright reiterated a Buy rating on CG Oncology, Inc.
11 Best Small-Cap Growth Stocks to Buy Right Now
On August 14, Jonathan Krinsky of BTIG joined CNBC for an interview to discuss the sustainability of the recent small-cap rally.
13 Best IPO Stocks to Buy According to Wall Street Analysts
On August 14, Tony Kim, Centerview Partners co-president, joined CNBC's 'Closing Bell: Overtime' to discuss the IPO market and the dealmaking environment.
Hedge Fund Resource Center Billionaire Hedge Funds
